[Association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid and preterm delivery in women].
Folic acid
Multiple-micronutrient
Periconceptional period
Premature birth
Journal
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
ISSN: 1671-167X
Titre abrégé: Beijing Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 101125284
Informations de publication
Date de publication:
18 Jun 2023
18 Jun 2023
Historique:
medline:
12
6
2023
pubmed:
9
6
2023
entrez:
9
6
2023
Statut:
ppublish
Résumé
To explore the association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid(MMFA) and risk of preterm delivery in women with natural conception, singleton pregnancy and vaginal delivery. A retrospective cohort study was performed based on the prenatal health care system and hospital information system of Tongzhou Maternal and Child Health Hospital of Beijing and the women who had their prenatal care in the hospital from January 2015 to December 2018 were included. The information of 16 332 women who conceived naturally, had a singleton pregnancy, and delivered vaginally was collected. Compliance scores were constructed based on the time of initiation and the frequency of taking nutritional supplements. The association between maternal periconceptional micronutrient supplementation, including pure folic acid (FA) pills or MMFA and the rate of preterm delivery was evaluated using Logistic regression models. The preterm delivery rate (gestational week < 37 weeks) of the study population was 3.8%, and the mean (standard deviation) of gestational age was (38.98±1.37) weeks. A total of 6 174 (37.8%) women took FA during the periconceptional period, 8 646 (52.9%) women took MMFA, and 1 512 (9.3%) women did not take any nutritional supplements. The association between periconceptional supplementation of FA or MMFA and risk of preterm delivery in women was not statistically significant [adjusted odds ratio (a This study did not find an association between the risk of preterm delivery and the use of FA or MMFA during the periconcep-tional period in women with natural conception, singleton pregnancy, and vaginal delivery. In the future, multicenter studies with large-scale prospective cohort or population-based randomized controlled trials are warranted to confirm the association between taking FA or MMFA during the periconceptional period and preterm delivery among women.
Substances chimiques
Folic Acid
935E97BOY8
Micronutrients
0
Types de publication
English Abstract
Journal Article
Langues
chi
Sous-ensembles de citation
IM
Pagination
495-501Références
Matern Child Nutr. 2020 Jan;16(1):e12895
pubmed: 31680411
Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:76-81
pubmed: 26901401
Lancet Glob Health. 2021 Sep;9(9):e1226-e1241
pubmed: 34416213
Int J Epidemiol. 2014 Aug;43(4):1132-9
pubmed: 24603317
Lancet Reg Health Am. 2022 May;9:
pubmed: 35692901
Am J Obstet Gynecol. 2017 Oct;217(4):404.e1-404.e30
pubmed: 28377269
Biomed Res Int. 2021 May 6;2021:6652231
pubmed: 34036101
Eur J Nutr. 2021 Jun;60(4):2181-2192
pubmed: 33074387
J Pediatr. 2022 Jan;240:72-78
pubmed: 34508748
Cochrane Database Syst Rev. 2019 Mar 14;3:CD004905
pubmed: 30873598
Nat Rev Endocrinol. 2016 May;12(5):274-89
pubmed: 27032981
Campbell Syst Rev. 2021 Jun 26;17(2):e1127
pubmed: 37051178
Br J Nutr. 2016 Feb 14;115(3):509-16
pubmed: 26651997
Hum Reprod Update. 2013 Nov-Dec;19(6):640-55
pubmed: 23959022
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
Front Pediatr. 2022 Apr 28;10:844404
pubmed: 35573945
Am J Clin Nutr. 2006 May;83(5):993-1016
pubmed: 16685040
BMJ Glob Health. 2022 Aug;7(8):
pubmed: 35948345
BMC Pregnancy Childbirth. 2021 Jul 7;21(1):492
pubmed: 34233654
N Engl J Med. 1999 Nov 11;341(20):1485-90
pubmed: 10559448